Edinburgh Research Explorer

Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trial

Research output: Contribution to journalArticle

Related Edinburgh Organisations

Open Access permissions

Open

Documents

http://bmjopen.bmj.com/content/3/9/e003054
Original languageEnglish
Article numbere003054
Number of pages8
JournalBMJ Open
Volume3
Issue number9
DOIs
Publication statusPublished - 2013

Abstract



Objective The mechanisms through which ω-3 fatty acids reduce adverse cardiac events remain uncertain. We aimed to investigate the effect of ω-3 fatty acid supplementation on endothelial vasomotor function, endogenous fibrinolysis, and platelet and monocyte activation in patients with coronary heart disease.

Design Randomised, double-blind, placebo-controlled, cross-over trial.

Setting Academic cardiac centre.

Participants 20 male patients with a previous myocardial infarction.

Intervention ω-3 Fatty acid supplementation (2 g/day for 6 weeks) versus olive oil placebo.

Outcome measures Peripheral blood was taken for analysis of platelet and monocyte activation, and forearm blood flow (FBF) was assessed in a subset of 12 patients during intrabrachial infusions of acetylcholine, substance P and sodium nitroprusside. Stimulated plasma tissue plasminogen activator (t-PA) concentrations were measured during substance P infusion.

Results All vasodilators caused dose-dependent increases in FBF (p<0.0001). ω-3 Fatty acid supplementation did not affect endothelium-dependent vasodilation with acetylcholine and substance P compared with placebo (p=0.5 and 0.9). Substance P caused a dose-dependent increase in plasma t-PA concentrations (p<0.0001), which was not affected by ω-3 fatty acid supplementation (p=0.9). ω-3 Fatty acids did not affect platelet–monocyte aggregation, platelet P-selectin or CD40L, or monocyte CD40.

Conclusions We have demonstrated that dietary supplementation with ω-3 fatty acids does not affect endothelial vasomotor function, endothelial t-PA release, or platelet and monocyte activation in patients with coronary heart disease. Cardiac benefits conferred by ω-3 fatty acids in coronary heart disease are unlikely to be mediated through effects on these systems.

    Research areas

  • POLYUNSATURATED FATTY-ACIDS, CORONARY-ARTERY-DISEASE, PLACEBO-CONTROLLED TRIAL, LONG-TERM TREATMENT, PLASMINOGEN-ACTIVATOR, EICOSAPENTAENOIC ACID, FISH-OIL, DIETARY SUPPLEMENTATION, DIABETES-MELLITUS, IN-VIVO

Download statistics

No data available

ID: 10145048